DR. SHIVANANDA MURGOD E; DR SUMAIRA AHMED; DR AHMED SHOQUEER; DR. MAJED ALHARBI; DR NAWAF ALMUTAIRI; DR. ABDULLAH ALQIFARI. EFFICACY OF SOFOSBUVIR/DACLATASVIR IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 4 INFECTION AT A SPECIALIST HOSPITAL. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 30, n. 18, p. 2818–2823, 2023. DOI: 10.53555/jptcp.v30i18.3544. Disponível em: https://jptcp.com/index.php/jptcp/article/view/3544. Acesso em: 27 jul. 2024.